149 related articles for article (PubMed ID: 31159579)
1. BAP1 in solid tumors.
Di Nunno V; Frega G; Santoni M; Gatto L; Fiorentino M; Montironi R; Battelli N; Brandi G; Massari F
Future Oncol; 2019 Jun; 15(18):2151-2162. PubMed ID: 31159579
[TBL] [Abstract][Full Text] [Related]
2. Roles and mechanisms of BAP1 deubiquitinase in tumor suppression.
Masclef L; Ahmed O; Estavoyer B; Larrivée B; Labrecque N; Nijnik A; Affar EB
Cell Death Differ; 2021 Feb; 28(2):606-625. PubMed ID: 33462414
[TBL] [Abstract][Full Text] [Related]
3. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
Marušić Z; Buljan M; Busam KJ
J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T
Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804
[TBL] [Abstract][Full Text] [Related]
5. Tumours associated with BAP1 mutations.
Murali R; Wiesner T; Scolyer RA
Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
[TBL] [Abstract][Full Text] [Related]
6. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
[TBL] [Abstract][Full Text] [Related]
7. Targeting BAP1: a new paradigm for mesothelioma.
Schunselaar LM; Zwart W; Baas P
Lung Cancer; 2017 Jul; 109():145-146. PubMed ID: 28342657
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis identifies novel binding partners of BAP1.
Baas R; J van der Wal F; Bleijerveld OB; van Attikum H; Sixma TK
PLoS One; 2021; 16(9):e0257688. PubMed ID: 34591877
[TBL] [Abstract][Full Text] [Related]
9. BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.
Shrestha R; Nabavi N; Lin YY; Mo F; Anderson S; Volik S; Adomat HH; Lin D; Xue H; Dong X; Shukin R; Bell RH; McConeghy B; Haegert A; Brahmbhatt S; Li E; Oo HZ; Hurtado-Coll A; Fazli L; Zhou J; McConnell Y; McCart A; Lowy A; Morin GB; Chen T; Daugaard M; Sahinalp SC; Hach F; Le Bihan S; Gleave ME; Wang Y; Churg A; Collins CC
Genome Med; 2019 Feb; 11(1):8. PubMed ID: 30777124
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
[TBL] [Abstract][Full Text] [Related]
11. Familial and Somatic
Peng H; Prokop J; Karar J; Park K; Cao L; Harbour JW; Bowcock AM; Malkowicz SB; Cheung M; Testa JR; Rauscher FJ
Cancer Res; 2018 Mar; 78(5):1200-1213. PubMed ID: 29284740
[TBL] [Abstract][Full Text] [Related]
12. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1.
Zhang Y; Koppula P; Gan B
Cell Cycle; 2019 Apr; 18(8):773-783. PubMed ID: 30907299
[TBL] [Abstract][Full Text] [Related]
13. Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.
Cheung M; Kadariya Y; Talarchek J; Pei J; Ohar JA; Kayaleh OR; Testa JR
Cancer Lett; 2015 Dec; 369(2):261-5. PubMed ID: 26409435
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
15. Gene of the month: BAP1.
Wang A; Papneja A; Hyrcza M; Al-Habeeb A; Ghazarian D
J Clin Pathol; 2016 Sep; 69(9):750-3. PubMed ID: 27235536
[TBL] [Abstract][Full Text] [Related]
16. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.
Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR
Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612
[TBL] [Abstract][Full Text] [Related]
17. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
Piris A; Mihm MC; Hoang MP
Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
[TBL] [Abstract][Full Text] [Related]
18. Roles of the BAP1 Tumor Suppressor in Cell Metabolism.
Han A; Purwin TJ; Aplin AE
Cancer Res; 2021 Jun; 81(11):2807-2814. PubMed ID: 33446574
[TBL] [Abstract][Full Text] [Related]
19. BAP1 links metabolic regulation of ferroptosis to tumour suppression.
Zhang Y; Shi J; Liu X; Feng L; Gong Z; Koppula P; Sirohi K; Li X; Wei Y; Lee H; Zhuang L; Chen G; Xiao ZD; Hung MC; Chen J; Huang P; Li W; Gan B
Nat Cell Biol; 2018 Oct; 20(10):1181-1192. PubMed ID: 30202049
[TBL] [Abstract][Full Text] [Related]
20. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.
Wadt KA; Aoude LG; Johansson P; Solinas A; Pritchard A; Crainic O; Andersen MT; Kiilgaard JF; Heegaard S; Sunde L; Federspiel B; Madore J; Thompson JF; McCarthy SW; Goodwin A; Tsao H; Jönsson G; Busam K; Gupta R; Trent JM; Gerdes AM; Brown KM; Scolyer RA; Hayward NK
Clin Genet; 2015 Sep; 88(3):267-72. PubMed ID: 25225168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
